Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.33
Delayed Data
As of Jun 30
 -0.05 / -3.62%
Today’s Change
1.24
Today|||52-Week Range
11.13
-83.06%
Year-to-Date

Today’s Trading

Previous close1.38
Today’s open1.38
Day’s range1.31 - 1.46
Volume2,201,231
Average volume (3 months)1,077,048
Market cap$64.8M
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)-627.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+101.00%
Revenue growth (last year)-33.90%
P/E ratioNM
Price/Sales3.53
Price/Book0.66

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...-0.02-0.66%
CATBCatabasis Pharmaceut...-0.31-7.73%
OREXOrexigen Therapeutic...-0.01-2.54%
CPRXCatalyst Pharmaceuti...0.000.00%
Data as of 06/30/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.87
Annual revenue (last year)$109.1M
Annual profit (last year)-$128.4M
Net profit margin-117.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Adelene Q. Perkins
Chief Financial Officer, Secretary &
Treasurer
Lawrence E. Bloch
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs